Cincinnati Eye Institute — Cincinnati, Ohio

Public research footprint of Cincinnati Eye Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Age-Related Macular Degeneration · Geographic Atrophy · Dry Age-related Macular Degeneration · X-Linked Retinitis Pigmentosa

Recently updated registry entries

NCT03683251 — Extension Study for the Port Delivery System With Ranibizumab (Portal) (Recruiting)
NCT06541704 — A Study Investigating Subcutaneously Administered Pozelimab in Combination With… (Recruiting)
NCT06971939 — Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cincinnati Eye Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.